# A Safety and Efficacy Study of Lepu® Drug Coated Balloon in Treatment of Coronary Small-vessel Disease

Study · id `cardio:ct-nct04953117` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04953117](<https://clinicaltrials.gov/study/NCT04953117>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04953117

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 286 participants.

## Technical summary

Registry record NCT04953117. Randomized; single masking; primary purpose treatment. Start 2021-03-10 (actual); primary completion 2022-06 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 286 participants (planned count; ClinicalTrials.gov record NCT04953117, source copy `cardio:ctgov-nct04953117-2021-07-07`, retrieved 2026-10-26)
- Started: 2021-03-10 (actual) (ClinicalTrials.gov record NCT04953117, source copy `cardio:ctgov-nct04953117-2021-07-07`, retrieved 2026-10-26)
- Primary completion: 2022-06 (anticipated) (ClinicalTrials.gov record NCT04953117, source copy `cardio:ctgov-nct04953117-2021-07-07`, retrieved 2026-10-26)
- Completion: 2023-04 (anticipated) (ClinicalTrials.gov record NCT04953117, source copy `cardio:ctgov-nct04953117-2021-07-07`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT04953117, source copy `cardio:ctgov-nct04953117-2021-07-07`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04953117-2021-07-07`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Safety and Efficacy Study of Lepu® Drug Coated Balloon in Treatment of Coronary Small-vessel Disease
- Condition: Coronary Artery Disease
- Intervention (Device): DCB of Lepu Medical(dimeter≥2.00 mm)
- Intervention (Device): Restore DEB
- Intervention (Device): DCB of Lepu Medical(dimeter&lt;2.00 mm)
- Lead sponsor: Lepu Medical Technology (Beijing) Co., Ltd.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Lepu Medical Technology (Beijing) Co., Ltd. (`cardio:org-lepu-medical-technology-beijing-co-ltd`)

## Provenance

Content hash: deb15e5d4e2779e8cf136ffddcd3c89ad9ca7ea19533bc5a7f75b836a77b3778
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
